Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.

Cancers (Basel) · 2023 · PMC10216345 · PMID 37345148

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not quite reach statistical significanceno p-value reported

The CCK-BR selective antagonist also slightly increased phosphorylation of downstream AKT in mPSC, but this value did not quite reach statistical significance. 3.2.

also in 147 other papers

did not reach statistical significanceno p-value reported

When mPSCs were treated with CCK peptide, the CCK-AR expression increased yet did not reach statistical significance.

also in 53,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.